MicroRNA-149 improves osteoarthritis via repression of VCAM-1 and inactivation of PI3K/AKT pathway

被引:11
|
作者
Jiang, Yongqin [1 ]
Zhang, Lei [1 ]
Tian, Huiyu [2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin 150086, Heilongjiang, Peoples R China
[2] Second Hosp Heilongjiang Prov, Dept Phys Diag, Liaoyuan Rd 50, Harbin 150001, Heilongjiang, Peoples R China
关键词
Osteoarthritis; MicroRNA-149; PI3K; AKT pathway; Vascular cell adhesion molecule-1; INFLAMMATORY RESPONSE; CELL; PROLIFERATION; CHONDROCYTES; INHIBITION; APOPTOSIS; AUTOPHAGY;
D O I
10.1016/j.exger.2023.112103
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: MicroRNAs (miRNAs) are key regulators in osteoarthritis (OA). While the role of miR-149 in OA has not been fully understood yet. This study investigated the mechanism in which miR-149 inhibited vascular cell adhesion molecule 1 (VCAM-1) via depressing PI3K/AKT pathway, thereby alleviating OA.Methods: A mouse OA model was constructed. The mice were injected with miR-149, VCAM-1- PI3K/AKT pathway-related sequences to figure their roles in OA. Inflammation and apoptosis were detected in the cartilage tissues of mice. MiR-149 and VCAM-1expression were detected. Results: Decreased miR-149 and enhanced VCAM-1 existed in cartilage tissues of patients with OA. Elevated miR149 or suppressed VCAM-1 limited inflammation and apoptosis in cartilage tissues of mice with OA, which was related to PI3K/AKT pathway inactivation.Conclusion: Our study provides evidence that up-regulated miR-149 alleviates OA via inhibition of VCAM-1 and PI3K/AKT pathway, which is helpful for OA treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Activation of latent HIV-1 via the PI3K/Akt signalling pathway
    Doyon, G.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2011, 16 : A36 - A36
  • [22] Pain mediator NGF improves chondrocyte extracellular matrix synthesis via PI3K/AKT pathway
    Wang, Mengling
    Lian, Jie
    Ye, Maoqing
    An, Bingchen
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2025, 20 (01):
  • [23] Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity via PI3K/Akt/mTOR Pathway
    Xie, Xinran
    Zhang, Lei
    Li, Xue
    Liu, Weihong
    Wang, Ping
    Lin, Yan
    Han, Xuyang
    Li, Ping
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Oleanolic Acid Improves the Symptom of Renal Ischemia Reperfusion Injury via the PI3K/AKT Pathway
    Yang, JinRan
    Li, Xinchang
    Yang, Hua
    Long, Chenmei
    UROLOGIA INTERNATIONALIS, 2021, 105 (3-4) : 215 - 220
  • [25] MicroRNA-130a regulates chondrocyte proliferation and alleviates osteoarthritis through PTEN/PI3K/Akt signaling pathway
    Zhang, Yun
    Xu, Shaochen
    Huang, Eric
    Zhou, Haichao
    Li, Bing
    Shao, Chenni
    Yang, Yunfeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (06) : 3699 - 3708
  • [26] Insulin upregulates betatrophin expression via PI3K/Akt pathway
    Lu, Puhan
    Chen, Xi
    Zhang, Zeqing
    Zhang, Jianhua
    Yang, Yan
    Liu, Zhelong
    Xie, Junhui
    Shao, Shiying
    Zhou, Xinrong
    Hu, Shuhong
    He, Wentao
    Zhao, Jiajun
    Yu, Xuefeng
    SCIENTIFIC REPORTS, 2017, 7
  • [27] Isorhamnetin Improves Oocyte Maturation by Activating the Pi3k/Akt Signaling Pathway
    Li, Xiaoya
    Cheng, Jianyong
    Yao, Qichun
    Duan, Jiaxin
    Chen, Huali
    Zhang, Zelin
    Yang, Li
    Hua, Rongmao
    Li, Qingwang
    MOLECULAR NUTRITION & FOOD RESEARCH, 2024, 68 (15)
  • [28] Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 via NF-κB induced by oxidative stress
    Kobayashi, N
    Mita, S
    Yoshida, K
    Honda, T
    Kobayashi, T
    Hara, K
    Nakano, S
    Tsubokou, Y
    Matsuoka, H
    HYPERTENSION, 2003, 42 (05) : 1004 - 1013
  • [29] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [30] Insulin upregulates betatrophin expression via PI3K/Akt pathway
    Puhan Lu
    Xi Chen
    Zeqing Zhang
    Jianhua Zhang
    Yan Yang
    Zhelong Liu
    Junhui Xie
    Shiying Shao
    Xinrong Zhou
    Shuhong Hu
    Wentao He
    Jiajun Zhao
    Xuefeng Yu
    Scientific Reports, 7